Artgen Biotech PJSC's latest marketcap:
As of 05/14/2025, Artgen Biotech PJSC's market capitalization has reached $51.67 M. According to our data, Artgen Biotech PJSC is the 29155th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 51.67 M |
| Revenue (ttm) | 18.34 M |
| Net Income (ttm) | 2.59 M |
| Shares Out | 71.99 M |
| EPS (ttm) | 0.03 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 04/28/2025 |
Artgen Biotech PJSC's yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 07/08/2022 | ₽4.29 B | -48.18% |
| 12/30/2021 | ₽8.27 B | 201.1% |
| 12/30/2020 | ₽2.75 B |
Company Profile
Artgen Biotech PJSC, a biotech company, engages in the development of healthcare products in Russia.
It develops Betuvax-CoV-2, a vaccine for SARS-COV-2; Tetraflubet, a Flu vaccination; Combi 5V, a Flu + COVID-19 booster vaccine; Betusphere for Immunomodulator; RBT-402, a HPV vaccine; and RBT-501, a vaccine for natural allergy.
The company also offers Histograft, a Gene-activated material used as an osteoplastic material, as well as biobanking, genetic research, and regenerative medicine services.
In addition, it develops various medical products, such as Xeno-Bone for bone grafting in open operations; Inject-Bone for minimally invasive bone grafting; Inject-Soft use for damage to the skin and mucous membranes; 3D-Bone use for replacement od volumetric bone defects; Cover Bone for guided bone regeneration; and Supl-Bone for bone grafting.
The company was formerly known as Public Joint-Stock Company "Human Stem Cells Institute". The company was founded in 2003 and is based in Moscow, Russia.
Frequently Asked Questions
-
What is Artgen Biotech PJSC's (MOEX-ISKJ) current market cap?As of 05/14/2025, Artgen Biotech PJSC (including the parent company, if applicable) has an estimated market capitalization of $51.67 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Artgen Biotech PJSC (MOEX-ISKJ) rank globally by market cap?Artgen Biotech PJSC global market capitalization ranking is approximately 29155 as of 05/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.